flu like symptoms with semaglutide Flu-Like on GLP-1: Causes and Management Ozempic (semaglutide) is a GLP-1

In a clinical study conducted over twelve months, patients who used semaglutide injections lost an average of 1520% of their body weight over a year, compared to the minimal weight loss results achieved by patients in control groups following diet and exercise plans

For example, A 2023 study in the New England Journal of Medicine found that semaglutide reduced the risk of death from heart disease and nonfatal heart attacks or strokes by about 20 percent for people who were obese or overweight

However, many doctors are wary of microdosing GLP-1s, especially in the absence of an actual medical condition

Standardized potency means each dose contains exactly the amount of medication specified

References (55) Graaf CD, Donnelly D, Wootten D, et al